Titan Medical Inc (TITXF) 1.3800 $TITXF
Global Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021
M2 - Thu May 14, 8:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lhrlvh/surgical_robots) has announced the addition of Wintergreen Research, Inc's new report "Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021" to their offering. Surgical robot device markets at $3.2 billion in 2014 are anticipated to reach $20 billion by 2021 as next generation devices, systems, and instruments are introduced to manage surgery through small ports in the body instead of large open wounds. The complete report provides a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players' success, challenges, and strategies in each segment and subsegment. The reports cover markets for: medical specialties and sub-specialties. The new study Surgical Robots: Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021 has 553 pages, 216 tables and figures. Worldwide surgical robot markets are poised to achieve significant growth as next generation systems provide a way to improve traditional open surgery and decrease the number of ports needed for minimally invasive surgery. Intuitive Surgical has market leadership position, advanced technology, an impressive installed base and a well trained group of surgeons able to manage the robots. Patients fare better when the surgery is done by surgical robots. The documentation of improvements in care delivery, the ability to ensure better outcomes from surgery promise that surgical robotics is a strong growth market. Intuitive Surgical will be difficult to dislodge, its dominant position is based on technological excellence that keeps being improved and competitors have a difficult time catching up, much less improving on the Intuitive Surgical technology. Other leading competitors will emerge and the group of several surgical robotic companies will collectively have enough marketing dollars and enough marketing clout to drive replacement of all open surgery. Robotic surgery is positioned to become the standard of care. Intuitive Surgical has achieved market saturation in colorectal surgery in the US, it will work on increasing its presence in other surgical market sectors. The leading robotic surgical companies are poised to grow through acquisition, purchasing smaller companies that have developed as specialized product and gained FDA approval. As detailed in the market research study there are a lot of those in every medical specialty and more to come. Key Topics Covered: 1. Surgical Robots Market Description and Market Dynamics 2. Surgical Robot Market Shares and Forecasts 3. Surgical Robots Product Description 4. Medical Robot Technology 5. Surgical Robots Company Description Companies Mentioned - AVRA Surgical - Accel Spine - Accuray - Aesynt / Health Robotics - Alliance Spine - Amedica - Elekta AB - Freehand 2010 - Globus Medical - Hansen Medical - Healthcare Robotics Lab - Intuitive Surgical - Johnson and Johnson / DePuy Synthes - Medrobotics - Medtronic - NLT Spine - NuVasive - Otto Bock HealthCare - Precision Spine - RTI Biologics / Pioneer Surgical Technology - Restoration Robotics - SI-BONE 503 - Spinal Elements - SpineGuard - Spineart - Spineology - Stryker - Think Surgical - Titan Medical - TranS1 - UC Berkeley - Varian Medical Systems. - Vecna Robotics - Victrex plc / Invibio - Vycor For more information visit http://www.researchandmarkets.com/research/lh...cal_robots Source: Wintergreen Research, Inc
ISRG: 503.66 (+1.31), JNJ: 102.30 (+0.47), RTIX: 6.48 (-0.06), VAR: 87.25 (-0.34), MDT: 76.42 (+0.16), HNSN: 1.01 (+0.11), GMED: 25.12 (-0.05)
Titan Medical Inc. Named to 2015 OTCQX Best 50
Marketwired - Wed May 13, 3:30PM CDT
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF) is pleased to announce it has been named to the 2015 OTCQX® Best 50, a ranking of 50 top performing companies traded on the OTCQX Best Marketplace last year.
TMD.TO: 1.65 (-0.02)
Titan Medical Inc. Announces Results for the Three Months Ended March 31, 2015
Marketwired - Tue May 12, 3:30PM CDT
Titan Medical Inc. ("Titan" or the "Company"
(TSX: TMD) (OTCQX: TITXF) today announced financial results for the three months ended March 31, 2015. All financial results are reported in U.S. dollars, unless otherwise stated.
TMD.TO: 1.65 (-0.02)
Titan Medical Inc. Adopts Shareholders Rights Plan
Marketwired - Fri May 08, 3:30PM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) Titan Medical Inc. announces that it has adopted a shareholder rights plan (the "Plan" effective May 8, 2015. The Company will be seeking shareholder approval of the Plan at its upcoming annual and special meeting of shareholders to be held on June 9, 2015.
TMD.TO: 1.65 (-0.02)
Titan Medical Inc. and Anne Arundel Medical Center's Innovation Center Announce Agreement for Development of a Comprehensive Training Curriculum for the Use of the SPORT(TM) Surgical System
Marketwired - Tue May 05, 6:31AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) today announced that it has signed an agreement with the James and Sylvia Earl Simulation to Advance Innovation and Learning (SAIL) center at Anne Arundel Medical Center (AAMC) in Annapolis, MD, for the development of a comprehensive curriculum for training and performance assessment. The curriculum would be developed for training the surgeons and surgical teams who would use Titan's SPORT(TM) Surgical System.
TMD.TO: 1.65 (-0.02)
Titan Medical Inc. Signs Agreement With Worldwide Supplier of Single Patient Use Robotic Tools
Marketwire Canada - Thu Apr 16, 8:07AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) today announced that it has signed an agreement with a worldwide supplier of endomechanical devices for the development and supply of single patient use robotic tools. Under the terms of the agreement, the supplier will create customized single patient use tools for Titan's SPORTa"c Surgical System.
TMD.TO: 1.65 (-0.02)
The Rise Of The Robots: The Story Of Titan Medical
Capital Screen - at Seeking Alpha - Mon Apr 13, 11:56AM CDT
ISRG: 503.66 (+1.31), TRXC: 3.90 (+0.06)
The Rise Of The Robots: Mazor Robotics, Intuitive Surgical
Capital Screen - at Seeking Alpha - Wed Apr 01, 7:06AM CDT
ISRG: 503.66 (+1.31), MZOR: 11.85 (+0.16), TRXC: 3.90 (+0.06)
Leading 100 medical technology companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7pc3fm/usacanada) has announced the addition of the "USA/Canada Medical Technology 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Health care technology assessment is a thriving industry in the United States, used by government, insurers, medical societies, hospitals, and other groups for their own purposes. Most of the top medical technology companies come from the United States. In general, trends show an increasing use of medical technology products with demand expected to grow some four percent in the United States. In Canada too, the medical device advancements help save the lives of patients by improving the accuracy of diagnoses, enhancing treatments and cure of diseases, reducing long-term disabilities and helping to provide better medical care. Covering a wide range of products, medical technology examples include pacemakers, artificial heart valves, hip implants, synthetic skin, scalpels, and medical laboratory diagnostic instruments. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in the USA/Canadian medical technology industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical technology companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical technology companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products Key Topics Covered: Introduction Analysis Section 1. Rankings of Medical Technology Companies of USA/Canada 1.1. Leading 100 Medical Technology Companies of USA/Canada (based on recent sales, net income, total assets, total equity) 1.2. Most Growing 25 Medical Technology Companies of USA/Canada 1.3. Most Profitable 25 Medical Technology Companies of USA/Canada 2. Stock Market Performance over 5 Years. Leading 25 Medical Technology Companies of USA/Canada News Section 3. Key News of Medical Technology Sector in USA/Canada for Year 2014 3.1 - Key Company News. By Country and Company 3.2 - Key Company News. By News Category 3.3 - Key Industry News. By News Category 4. International Alliances of Medical Technology Companies in USA/Canada 5. International Presence of USA/Canadian Medical Technology Companies 6. Research and Development Activities in USA/Canadian Medical Technology Industry 7. Mergers and Acquisitions in USA/Canadian Medical Technology Industry Companies Mentioned (Partial List) - LED Medical Diagnostics Incorporated (Canada) - Masimo Corporation (United States) - Mazor Robotics Ltd (United States) - Medtronic, Incorporated (United States) - Mela Sciences Incorporation (United States) - Novation Holdings, Inc. (United States) - Oncologix Tech, Inc. (United States) - Pathfinder Cell Therapy Inc (United States) - Positron Corporation (United States) - Revolutions Medical Corporation (United States) - Rockwell Medical Incorporated (United States) - SQI Diagnostics Inc. (Canada) - The Cooper Companies, Inc. (United States) - Titan Medical Inc. (Canada) For more information visit http://www.researchandmarkets.com/research/7pc3fm/usacanada
MASI: 34.63 (unch), MDT: 76.42 (+0.16), MZOR: 11.85 (+0.16)
Titan Medical Inc. Adopts Amendment to By-Laws Requiring Advance Notice of Nomination of Directors
Marketwired - Fri Mar 20, 3:15PM CDT
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF) ("TMD" or the "Company" announced today that it has adopted an amendment to its by-laws, similar to by-law amendments and policies recently adopted by a number of other Canadian public companies, requiring advance notice to the Company for nominations of directors by shareholders other than through a requisitioned meeting or shareholder proposal pursuant to applicable corporate laws.
TMD.TO: 1.65 (-0.02)
Titan Medical Inc. Completes the Next Major Milestone in the Development of the SPORT(TM) Surgical System -- The Design and Test of a Feasibility Prototype
Marketwired - Tue Mar 17, 4:07PM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) today announced that it has completed the next major milestone in the development of the SPORT(TM) Surgical System -- the design and test of a feasibility prototype. It demonstrates feasibility to build a next generation workstation and advanced instruments, and it enables expanded use of the SPORT Surgical System.
TMD.TO: 1.65 (-0.02)
Titan Medical Inc. Announces Results for Fiscal Year Ended December 31, 2014
Marketwired - Tue Feb 10, 4:38PM CST
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) today announced financial results for the fiscal year ended December 31, 2014. All financial results are reported in U.S. dollars, unless otherwise stated.
TMD.TO: 1.65 (-0.02)
Global Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021
M2 - Thu May 14, 8:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lhrlvh/surgical_robots) has announced the addition of Wintergreen Research, Inc's new report "Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021" to their offering. Surgical robot device markets at $3.2 billion in 2014 are anticipated to reach $20 billion by 2021 as next generation devices, systems, and instruments are introduced to manage surgery through small ports in the body instead of large open wounds. The complete report provides a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players' success, challenges, and strategies in each segment and subsegment. The reports cover markets for: medical specialties and sub-specialties. The new study Surgical Robots: Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021 has 553 pages, 216 tables and figures. Worldwide surgical robot markets are poised to achieve significant growth as next generation systems provide a way to improve traditional open surgery and decrease the number of ports needed for minimally invasive surgery. Intuitive Surgical has market leadership position, advanced technology, an impressive installed base and a well trained group of surgeons able to manage the robots. Patients fare better when the surgery is done by surgical robots. The documentation of improvements in care delivery, the ability to ensure better outcomes from surgery promise that surgical robotics is a strong growth market. Intuitive Surgical will be difficult to dislodge, its dominant position is based on technological excellence that keeps being improved and competitors have a difficult time catching up, much less improving on the Intuitive Surgical technology. Other leading competitors will emerge and the group of several surgical robotic companies will collectively have enough marketing dollars and enough marketing clout to drive replacement of all open surgery. Robotic surgery is positioned to become the standard of care. Intuitive Surgical has achieved market saturation in colorectal surgery in the US, it will work on increasing its presence in other surgical market sectors. The leading robotic surgical companies are poised to grow through acquisition, purchasing smaller companies that have developed as specialized product and gained FDA approval. As detailed in the market research study there are a lot of those in every medical specialty and more to come. Key Topics Covered: 1. Surgical Robots Market Description and Market Dynamics 2. Surgical Robot Market Shares and Forecasts 3. Surgical Robots Product Description 4. Medical Robot Technology 5. Surgical Robots Company Description Companies Mentioned - AVRA Surgical - Accel Spine - Accuray - Aesynt / Health Robotics - Alliance Spine - Amedica - Elekta AB - Freehand 2010 - Globus Medical - Hansen Medical - Healthcare Robotics Lab - Intuitive Surgical - Johnson and Johnson / DePuy Synthes - Medrobotics - Medtronic - NLT Spine - NuVasive - Otto Bock HealthCare - Precision Spine - RTI Biologics / Pioneer Surgical Technology - Restoration Robotics - SI-BONE 503 - Spinal Elements - SpineGuard - Spineart - Spineology - Stryker - Think Surgical - Titan Medical - TranS1 - UC Berkeley - Varian Medical Systems. - Vecna Robotics - Victrex plc / Invibio - Vycor For more information visit http://www.researchandmarkets.com/research/lh...cal_robots Source: Wintergreen Research, Inc
ISRG: 503.66 (+1.31), JNJ: 102.30 (+0.47), RTIX: 6.48 (-0.06), VAR: 87.25 (-0.34), MDT: 76.42 (+0.16), HNSN: 1.01 (+0.11), GMED: 25.12 (-0.05)
Titan Medical Inc. Named to 2015 OTCQX Best 50
Marketwired - Wed May 13, 3:30PM CDT
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF) is pleased to announce it has been named to the 2015 OTCQX® Best 50, a ranking of 50 top performing companies traded on the OTCQX Best Marketplace last year.
TMD.TO: 1.65 (-0.02)
Titan Medical Inc. Announces Results for the Three Months Ended March 31, 2015
Marketwired - Tue May 12, 3:30PM CDT
Titan Medical Inc. ("Titan" or the "Company"
(TSX: TMD) (OTCQX: TITXF) today announced financial results for the three months ended March 31, 2015. All financial results are reported in U.S. dollars, unless otherwise stated. TMD.TO: 1.65 (-0.02)
Titan Medical Inc. Adopts Shareholders Rights Plan
Marketwired - Fri May 08, 3:30PM CDT
Titan Medical Inc. ("Titan" or the "Company"
(TSX: TMD) (OTCQX: TITXF) Titan Medical Inc. announces that it has adopted a shareholder rights plan (the "Plan" effective May 8, 2015. The Company will be seeking shareholder approval of the Plan at its upcoming annual and special meeting of shareholders to be held on June 9, 2015. TMD.TO: 1.65 (-0.02)
Titan Medical Inc. and Anne Arundel Medical Center's Innovation Center Announce Agreement for Development of a Comprehensive Training Curriculum for the Use of the SPORT(TM) Surgical System
Marketwired - Tue May 05, 6:31AM CDT
Titan Medical Inc. ("Titan" or the "Company"
(TSX: TMD) (OTCQX: TITXF) today announced that it has signed an agreement with the James and Sylvia Earl Simulation to Advance Innovation and Learning (SAIL) center at Anne Arundel Medical Center (AAMC) in Annapolis, MD, for the development of a comprehensive curriculum for training and performance assessment. The curriculum would be developed for training the surgeons and surgical teams who would use Titan's SPORT(TM) Surgical System. TMD.TO: 1.65 (-0.02)
Titan Medical Inc. Signs Agreement With Worldwide Supplier of Single Patient Use Robotic Tools
Marketwire Canada - Thu Apr 16, 8:07AM CDT
Titan Medical Inc. ("Titan" or the "Company"
(TSX: TMD) (OTCQX: TITXF) today announced that it has signed an agreement with a worldwide supplier of endomechanical devices for the development and supply of single patient use robotic tools. Under the terms of the agreement, the supplier will create customized single patient use tools for Titan's SPORTa"c Surgical System. TMD.TO: 1.65 (-0.02)
The Rise Of The Robots: The Story Of Titan Medical
Capital Screen - at Seeking Alpha - Mon Apr 13, 11:56AM CDT
ISRG: 503.66 (+1.31), TRXC: 3.90 (+0.06)
The Rise Of The Robots: Mazor Robotics, Intuitive Surgical
Capital Screen - at Seeking Alpha - Wed Apr 01, 7:06AM CDT
ISRG: 503.66 (+1.31), MZOR: 11.85 (+0.16), TRXC: 3.90 (+0.06)
Leading 100 medical technology companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7pc3fm/usacanada) has announced the addition of the "USA/Canada Medical Technology 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Health care technology assessment is a thriving industry in the United States, used by government, insurers, medical societies, hospitals, and other groups for their own purposes. Most of the top medical technology companies come from the United States. In general, trends show an increasing use of medical technology products with demand expected to grow some four percent in the United States. In Canada too, the medical device advancements help save the lives of patients by improving the accuracy of diagnoses, enhancing treatments and cure of diseases, reducing long-term disabilities and helping to provide better medical care. Covering a wide range of products, medical technology examples include pacemakers, artificial heart valves, hip implants, synthetic skin, scalpels, and medical laboratory diagnostic instruments. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in the USA/Canadian medical technology industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical technology companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical technology companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products Key Topics Covered: Introduction Analysis Section 1. Rankings of Medical Technology Companies of USA/Canada 1.1. Leading 100 Medical Technology Companies of USA/Canada (based on recent sales, net income, total assets, total equity) 1.2. Most Growing 25 Medical Technology Companies of USA/Canada 1.3. Most Profitable 25 Medical Technology Companies of USA/Canada 2. Stock Market Performance over 5 Years. Leading 25 Medical Technology Companies of USA/Canada News Section 3. Key News of Medical Technology Sector in USA/Canada for Year 2014 3.1 - Key Company News. By Country and Company 3.2 - Key Company News. By News Category 3.3 - Key Industry News. By News Category 4. International Alliances of Medical Technology Companies in USA/Canada 5. International Presence of USA/Canadian Medical Technology Companies 6. Research and Development Activities in USA/Canadian Medical Technology Industry 7. Mergers and Acquisitions in USA/Canadian Medical Technology Industry Companies Mentioned (Partial List) - LED Medical Diagnostics Incorporated (Canada) - Masimo Corporation (United States) - Mazor Robotics Ltd (United States) - Medtronic, Incorporated (United States) - Mela Sciences Incorporation (United States) - Novation Holdings, Inc. (United States) - Oncologix Tech, Inc. (United States) - Pathfinder Cell Therapy Inc (United States) - Positron Corporation (United States) - Revolutions Medical Corporation (United States) - Rockwell Medical Incorporated (United States) - SQI Diagnostics Inc. (Canada) - The Cooper Companies, Inc. (United States) - Titan Medical Inc. (Canada) For more information visit http://www.researchandmarkets.com/research/7pc3fm/usacanada
MASI: 34.63 (unch), MDT: 76.42 (+0.16), MZOR: 11.85 (+0.16)
Titan Medical Inc. Adopts Amendment to By-Laws Requiring Advance Notice of Nomination of Directors
Marketwired - Fri Mar 20, 3:15PM CDT
Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF) ("TMD" or the "Company"
announced today that it has adopted an amendment to its by-laws, similar to by-law amendments and policies recently adopted by a number of other Canadian public companies, requiring advance notice to the Company for nominations of directors by shareholders other than through a requisitioned meeting or shareholder proposal pursuant to applicable corporate laws. TMD.TO: 1.65 (-0.02)
Titan Medical Inc. Completes the Next Major Milestone in the Development of the SPORT(TM) Surgical System -- The Design and Test of a Feasibility Prototype
Marketwired - Tue Mar 17, 4:07PM CDT
Titan Medical Inc. ("Titan" or the "Company"
(TSX: TMD) (OTCQX: TITXF) today announced that it has completed the next major milestone in the development of the SPORT(TM) Surgical System -- the design and test of a feasibility prototype. It demonstrates feasibility to build a next generation workstation and advanced instruments, and it enables expanded use of the SPORT Surgical System. TMD.TO: 1.65 (-0.02)
Titan Medical Inc. Announces Results for Fiscal Year Ended December 31, 2014
Marketwired - Tue Feb 10, 4:38PM CST
Titan Medical Inc. ("Titan" or the "Company"
(TSX: TMD) (OTCQX: TITXF) today announced financial results for the fiscal year ended December 31, 2014. All financial results are reported in U.S. dollars, unless otherwise stated. TMD.TO: 1.65 (-0.02)
